Literature DB >> 29970353

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications.

Sebastian Ewen1, Lucas Lauder, Michel Azizi, David E Kandzari, Atul Pathak, Faisal Sharif, William Wijns, Felix Mahfoud, Thomas F Lüscher.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29970353     DOI: 10.4244/EIJY18M07_1

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  1 in total

1.  Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation.

Authors:  Abraham Rami Tzafriri; Fernando Garcia-Polite; John Keating; Raffaele Melidone; Jennifer Knutson; Peter Markham; Elazer R Edelman; Felix Mahfoud
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.